|
HK1214824A1
|
|
Process for preparing 5-amino-1, 2, 3-triazole orotate derivatives 5--123-
|
|
CA2863873A1
|
|
Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
|
|
AP201206187A0
|
|
Novel compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations.
|
|
US2008139592A1
|
|
Use of carboxiamidotriazole (CAI) orotate in macular degeneration
|
|
CN101273988A
|
|
Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
|
|
CA2575902A1
|
|
Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
|
